some peptide-industry sources report a Pharmacy Compounding Advisory Committee review was scheduled for July 2026 that could revisit this status, but that outcome had not been independently confirmed as of this writing
In a 2018 study published in Current Pharmaceutical Design , researchers compared the effectiveness of BPC-157 to that of various standard peptidergic angiogenic growth factors (EGF, FGF, and VEGF) and numerous carriers for treating gastrointestinal ulcer healing and tendon, ligament, muscle, and bone healing
Proper storage (usually in the refrigerator) and following safety tips are key for good results
For a broader overview of fragment peptides and how they fit into modern research programs, see our complete guide to peptides
If the goal is related to muscles, tendons, ligaments, or joints, a provider may discuss injectable BPC-157 because it does not have to pass through digestion first
The review documented GHK-Cus ability to promote balanced collagen synthesis, accelerate epithelialisation, and reduce fibrosis in both in vitro and pre-clinical models